DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 202 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $589 | +23.7% | 27,429 | +18.8% | 0.06% | +29.2% |
| Q3 2023 | $476 | +81.0% | 23,089 | +102.1% | 0.05% | +100.0% |
| Q1 2023 | $263 | -99.9% | 11,423 | +60.0% | 0.02% | +9.1% |
| Q3 2022 | $219,000 | -59.6% | 7,140 | -41.3% | 0.02% | -63.3% |
| Q4 2021 | $542,000 | +44.5% | 12,160 | +85.1% | 0.06% | +42.9% |
| Q1 2021 | $375,000 | -5.5% | 6,570 | -61.6% | 0.04% | -35.4% |
| Q1 2019 | $397,000 | +91.8% | 17,104 | +25.9% | 0.06% | +109.7% |
| Q2 2018 | $207,000 | – | 13,585 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
| Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
| Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
| Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
| MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
| Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
| PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
| WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |